Replies to post #520082 on NorthWest Biotherapeutics Inc (NWBO)

[OilPatch]

Thanks for the reply ;-)

[Horseb4CarT]

It couldn’t hurt! (Rim shot)

Imo the multiple shots on goal and the checks and balances of the multi nation trial was genius in many respects.

UK approval would put extra scrutiny on the FDA decision imo, thus I would think the FDA decision makers would need more solid reasons for not approving. Also, there would be potential for survival statistics and wonderfully positive patient outcomes from the UK versus status quo poorer results in the US also putting the FDA in an undesirable light.

[sentiment_stocks]

Yes I do. IMO, it (even if its minimal) helps to give the FDA cover to approve DCVax-L over any possible BP objections to the use of ECAs. And perhaps there won't even be objections, as the use of ECAs will certainly help to reduce the costs for trials, encourage more patient enrollment, which BPs may very possibly consider beneficial to their own goals as well.

This is only my opinion, of course, but I think it's reasonably supported.